Sat Kartar Life vs Sun Pharmaceutical Industries Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Sat Kartar Life currently has the stronger revenue growth signal.
Sat Kartar Life and Sun Pharmaceutical Industries Ltd show active capex signals based on earnings call analysis.
Sun Pharmaceutical Industries Ltd show fundraising activity or capital structure signals.
| Metric | Sat Kartar Life | Sun Pharmaceutical Industries Ltd |
|---|---|---|
| Current Price | ₹120 | ₹1,951 |
| Market Cap | ₹196.02 Cr. | ₹4.66 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 11.36 | 36.92 |
| ROE (%) | 28.97 | 15.95 |
| Debt/Equity | 0.04 | 0.06 |
| Sales Growth 5Y (%) | — | 11.78 |
| Profit Growth 5Y (%) | -14.12 | 14.45 |
| Promoter Holding (%) | 63.62 | 54.48 |
| Revenue Rank | Rank 2 | Rank 4 |
| Margin Rank | Rank 1 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | Yes |